Big Pharma Fund Fights Menacing Superbugs
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050. At the start of a long, uphill battle, big pharma is helping bring some novel antibiotics to market.